Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
This is a United States Department of Defense funded Focused Program study that aims to
identify mechanisms and predictors for persistent of post-traumatic headache attributed to
mild traumatic brain injury, and identify methods of preventing post-traumatic headache
persistence.
The objective of the clinical trial component of the Focused Program is to determine whether
intervention with erenumab is an effective treatment for PTH attributed to mTBI.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Amgen Arizona State University Phoenix VA Health Care System Translational Genomics Research Institute United States Department of Defense University of Arizona